Is a complete INCY research report available?

No complete published report is available for Incyte Corporation (INCY) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

INCY Stock Analysis, Forecast & Valuation

Market cap	25.8B
Revenue (ttm)	5.8B
Net income (ttm)	1.6B
EPS (ttm)	$7.85
Shares out	202.7M
P/E (trailing)	16.2x
P/E (forward)	51.8x
Volume	2,917,666
Beta	0.76

Price target	$122	-4.2%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All INCY indicators

Market & fundamental data

Available fields

281

Groups with data

Currency

USD

Showing 281 of 281 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000879169
Company name	Incyte Corporation
Country	United States
Country code	US
Cusip	45337C102
Employees	2,844
Employees Change	227%
Employees Change Percent	8.67
Enterprise value	$21.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Biotechnology
IPO Date	1993-11-04
Isin	US45337C1027
Last refreshed	2026-07-30
Market cap	$25.8B
Market cap category	Large-Cap
Price	$127
Price currency	USD
Rev Per Employee	2,046,248.24x
Sector	Healthcare
Sector PE	45.63
Sector PE Fwd	24.38
Sic	8731
Symbol	INCY
Website	https://www.incyte.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.26%
EV Earnings	13.19x
EV Sales Forward	3.63x
EV/EBIT	11.96x
EV/EBITDA	11.33x
EV/FCF	11.07x
EV/Sales	3.65x
FCF yield	7.45%
Forward P/E	51.78x
P/B ratio	4.03x
P/E ratio	16.19x
P/S ratio	4.43x
PE Ratio10 Y	89.69x
PE Ratio3 Y	136.11x
PE Ratio5 Y	93.62x
PEG ratio	4.29x
PS Forward	4.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.56%
EBITDA Margin	32.25%
FCF margin	33%
Gross margin	55.66%
Gross Profit	$3.2B
Gross Profit Growth	42.32%
Gross Profit Growth Q	63.92%
Gross Profit Growth3 Y	26.96%
Gross Profit Growth5 Y	25.5%
Net Income	$1.6B
Net Income Growth	85.15%
Net Income Growth Q	44.59%
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Net Income Growth3 Y	63.86%
Net Income Growth5 Y	36.71%
Pretax Margin	33.81%
Profit Margin	27.71%
Profit Per Employee	$566,942
Profitable Quarters	$8
Profitable Years	5
ROA	16.83
Roa5y	7.33
ROCE	27.11
ROE	30.67
Roe5y	16.25
ROIC	86.52
Roic5y	36.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.73%
Cagr15y	14.17%
Cagr1y	81.23%
Cagr20y	18.53%
Cagr3y	26.29%
Cagr5y	10.26%
EPS Growth	79.72
EPS Growth Q	37.75
EPS Growth Quarters	7
EPS Growth Years	1
EPS Growth3 Y	68.82
EPS Growth5 Y	38.85
FCF Growth	100.45%
FCF Growth Q	1,829.52%
FCF Growth3 Y	39.16%
FCF Growth5 Y	33.68%
OCF Growth	97.4%
OCF Growth Q	1,034.67%
OCF Growth10 Y	26.22%
OCF Growth3 Y	36.35%
OCF Growth5 Y	24.25%
Revenue Growth	26.93x
Revenue Growth Q	37.72x
Revenue Growth Quarters	33x
Revenue Growth Years	14x
Revenue Growth3 Y	18.32x
Revenue Growth5 Y	16.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.85
Assets	$7.9B
Cash	$4.5B
Current Assets	$6B
Current Liabilities	$1.3B
Debt	$38.3M
Debt EBITDA	$0.02
Debt Equity	$0.01
Debt FCF	$0.02
Equity	$6.3B
Interest Coverage	764.9
Liabilities	$1.5B
Long Term Assets	$1.8B
Long Term Liabilities	$216.1M
Net Cash	$4.5B
Net Cash By Market Cap	$17.46
Net Cash Growth	89.02%
Net Debt EBITDA	$-2.4
Net Debt Equity	$-0.71
Net Debt FCF	$-2.34
Tangible Book Value	$6.1B
Tangible Book Value Per Share	$30.39
WACC	8.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.59
Inventory Turnover	26.34
Net Working Capital	$188.6M
Quick ratio	4.31
Working Capital	$4.7B
Working Capital Turnover	$1.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.09%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	44.24%
1Y total return	81.16%
200-day SMA	100.9
3Y total return	101.46%
50-day SMA	108.1
50-day SMA vs 200-day SMA	50over200
5Y total return	62.93%
All Time High	153.2
All Time High Change	-17.01%
All Time High Date	2017-03-15
All Time Low	1.66
All Time Low Change	7,575.12%
All Time Low Date	1994-09-22
ATR	4.18
Beta	0.76
Beta1y	0.23
Beta2y	0.4
Ch YTD	28.68
High	130
High52	132.6
High52 Date	2026-07-28
High52ch	-4.15%
Low	125.8
Low52	71
Low52 Date	2025-07-29
Low52ch	79.01%
Ma50ch	17.58%
Premarket Change Percent	-0.7
Premarket Price	$129
Premarket Volume	1,664
Price vs 200-day SMA	25.98%
RSI	69.9
RSI Monthly	76.43
RSI Weekly	76.07
Sharpe ratio	1.78x
Sortino ratio	3.21
Total Return	-3.09%
Tr YTD	28.68
Tr15y	629.62%
Tr1m	11.74%
Tr1w	9.77%
Tr3m	30.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	26
Analyst Count Top	16
Analyst Price Target Top	$125
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$1.84
Earnings EPS Estimate Growth	17.2
Earnings Revenue Estimate	1,387,188,464x
Earnings Revenue Estimate Growth	14.08x
Operating Income	$1.8B
Operating Income Growth	90.8
Operating Income Growth Q	125.1
Operating Income Growth3 Y	60.42
Operating Income Growth5 Y	33.87
Operating margin	31.69
Price target	$122
Price Target Change	$-4.23
Price Target Change Top	$-1.28

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	167,478,886%
Float Percent	82.62%
Net Borrowing	-4,641,000
Shares Insiders	0.48%
Shares Institutions	88.14%
Shares Out	202,697,746
Shares Qo Q	0.67%
Shares Yo Y	3.09%
Short Float	6.28%
Short Ratio	5.32
Short Shares	5.19

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.7B
Adjusted OCF	1,724,559,000
Average Volume	1,875,368.95x
Bv Per Share	31.57
CAPEX	$-59.2M
Ch10y	44.24
Ch15y	629.6
Ch1m	11.74
Ch1w	9.77
Ch1y	81.16
Ch20y	2,897.6
Ch3m	30.04
Ch3y	101.5
Ch5y	62.93
Ch6m	25.62
Change	-2.18%
Change From Open	-1.37
Close	129.9
Days Gap	-0.82
Depreciation Amortization	98,283,000
Dollar Volume	370,835,348.6
Earnings Date	2026-07-28
Earnings Time	bmo
EBIT	$1.8B
EBITDA	$1.9B
EPS	$7.85
F Score	6
FCF	$1.9B
FCF EV Yield	9.03x
FCF Per Share	$9.47
Financing CF	275,239,000
Fiscal Year End	December
Founded	1,991
Goodwill	133,000,000
Graham Number	74.67305
Graham Upside	-41.25
Income Tax	$355M
Investing CF	-224,831,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-28
Last Report Date	2026-06-30
Last Split Date	2000-09-01
Last Split Type	Forward
Last10k Filing Date	2026-02-10
Lynch Fair Value	$196
Lynch Upside	54.42
Ma150	101.9
Ma150ch	24.7%
Ma20	117.7
Ma20ch	7.99%
Net CF	2,027,378,000
Next Earnings Date	2026-10-27
Open	128.9
Optionable	Yes
P FCF Ratio	13.41
P FCF Ratio SBC	15.47
P OCF Ratio	13.01
P OCF Ratio SBC	14.94
Position In Range	30.83
Post Close	127.1
Postmarket Change Percent	0.45
Postmarket Price	$128
Ppne	735,028,000
Pre Close	129.9
Price Date	2026-07-29
Price EBITDA	$13.73
Ptbv Ratio	4.22
Relative Volume	1.56x
Revenue	5,819,530,000x
SBC By Revenue	4.38x
Share Based Comp	255,144,000
Tax By Revenue	6.1x
Tax Rate	18.04%
Tr20y	2,897.64%
Tr6m	25.62%
Us State	Delaware
Volume	2,917,666
Z Score	9.67

Incyte Corporation (INCY)

Coverage state: Market snapshot only — no published research

Generate the first INCY analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · INCY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INCY indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on INCY

Frequently asked questions